Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-001177

Chief Operating Officer sold 3,499 shares at $5.33 ($18,642)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bertrand William C JR Chief Operating Officer 2021-01-04 Sale −3,499 $5.33 $18,642 5,864 D
Open-market sales · 3,499 sh · avg $5.33 · $18,642
Loading xslF345X03/tm211506-3_4seq1.xml…